Our Mission: Improving and Extending the Lives of Patients with Cancer
 
 
 

Publications

Manuscripts, Abstracts and Posters

General  |  view

CPX-351  |  view

CPX-1  |  view

CPX-571  |  view

CPX-8 / Nanoparticle Prodrug Delivery  |  view

Other  |  view

 

 

 


CombiPlex® technology is a novel approach that identifies molar ratios of drugs that will deliver a synergistic benefit and locks the desired ratio in a nano-scale drug delivery vehicle that delivers and maintains the ratio in patients with the goal of improving clinical outcomes.

 

\

 

 

 

 
© 2009 Celator Pharmaceuticals, Inc. All rights reserved. Celator®, Celator Pharmaceuticals®, the Celator logo and CombiPlex® are registered trademarks of Celator Pharmaceuticals, Inc. Contact webmaster.